These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1646923)

  • 1. Enantioselective kappa opioid binding sites on the macrophage cell line, P388d1.
    Carr DJ; DeCosta BR; Jacobson AE; Rice KC; Blalock JE
    Life Sci; 1991; 49(1):45-51. PubMed ID: 1646923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
    de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
    J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.
    Rothman RB; France CP; Bykov V; De Costa BR; Jacobson AE; Woods JH; Rice KC
    Eur J Pharmacol; 1989 Aug; 167(3):345-53. PubMed ID: 2553442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of N-substituted cis-N-methyl-2-(1-pyrrolidinyl)cyclohexylamines as high affinity sigma receptor ligands. Identification of a new class of highly potent and selective sigma receptor probes.
    de Costa BR; Rice KC; Bowen WD; Thurkauf A; Rothman RB; Band L; Jacobson AE; Radesca L; Contreras PC; Gray NM
    J Med Chem; 1990 Nov; 33(11):3100-10. PubMed ID: 2172538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the stereochemistry of the kappa-selective opioid agonist U50,488 result in high-affinity sigma ligands.
    de Costa BR; Bowen WD; Hellewell SB; George C; Rothman RB; Reid AA; Walker JM; Jacobson AE; Rice KC
    J Med Chem; 1989 Aug; 32(8):1996-2002. PubMed ID: 2547074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of an affinity ligand ('UPHIT') for in vivo acylation of the kappa-opioid receptor.
    de Costa BR; Band L; Rothman RB; Jacobson AE; Bykov V; Pert A; Rice KC
    FEBS Lett; 1989 Jun; 249(2):178-82. PubMed ID: 2544446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective reversible and irreversible ligands for the kappa opioid receptor.
    Cheng CY; Wu SC; Hsin LW; Tam SW
    J Med Chem; 1992 Jun; 35(12):2243-7. PubMed ID: 1319495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure.
    Joseph DB; Bidlack JM
    J Pharmacol Exp Ther; 1995 Mar; 272(3):970-6. PubMed ID: 7891351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein.
    Lawrence DM; Bidlack JM
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1678-83. PubMed ID: 8103800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
    Su TP
    J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective and enantiospecific acylation of kappa opioid receptors by (1S,2S)-trans-2-isothiocyanato-N-methyl-N-[2-(1-pyrrolidinyl) cyclohexy l] benzeneacetamide. Demonstration of kappa receptor heterogeneity.
    de Costa BR; Rothman RB; Bykov V; Jacobson AE; Rice KC
    J Med Chem; 1989 Feb; 32(2):281-3. PubMed ID: 2536435
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of high affinity opioid binding sites in rat periaqueductal gray P2 membrane.
    Fedynyshyn JP; Kwiat G; Lee NM
    Eur J Pharmacol; 1989 Jan; 159(1):83-8. PubMed ID: 2540013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly selective kappa opioid analgesics. 4. Synthesis of some conformationally restricted naphthalene derivatives with high receptor affinity and selectivity.
    Halfpenny PR; Horwell DC; Hughes J; Humblet C; Hunter JC; Neuhaus D; Rees DC
    J Med Chem; 1991 Jan; 34(1):190-4. PubMed ID: 1846919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50, 488H.
    Belkowski SM; Alicea C; Eisenstein TK; Adler MW; Rogers TJ
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1491-6. PubMed ID: 7791124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
    Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertussis and cholera toxins modulate kappa-opioid receptor agonists-induced hypothermia and gut inhibition.
    Shukla VK; Turndorf H; Bansinath M
    Eur J Pharmacol; 1995 Mar; 292(3-4):293-9. PubMed ID: 7796869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium channel blocking actions of the kappa-opioid receptor agonist U50,488 contribute to its visceral antinociceptive effects.
    Su X; Joshi SK; Kardos S; Gebhart GF
    J Neurophysiol; 2002 Mar; 87(3):1271-9. PubMed ID: 11877501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.
    Emmerson PJ; Liu MR; Woods JH; Medzihradsky F
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1630-7. PubMed ID: 7996478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of kappa opioids in rhesus monkeys: behavioral effects and receptor binding affinities.
    France CP; Medzihradsky F; Woods JH
    J Pharmacol Exp Ther; 1994 Jan; 268(1):47-58. PubMed ID: 8301589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential agonist regulation of the human kappa-opioid receptor.
    Blake AD; Bot G; Li S; Freeman JC; Reisine T
    J Neurochem; 1997 May; 68(5):1846-52. PubMed ID: 9109509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.